Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach
- PMID: 24303025
- PMCID: PMC3841158
- DOI: 10.1371/journal.pone.0080751
Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach
Abstract
Psoriasis is a multifactorial inflammatory skin disease characterized by increased proliferation of keratinocytes, activation of immune cells and susceptibility to metabolic syndrome. Systems biology approach makes it possible to reveal novel important factors in the pathogenesis of the disease. Protein-protein, protein-DNA, merged (containing both protein-protein and protein-DNA interactions) and chemical-protein interaction networks were constructed consisting of differentially expressed genes (DEG) between lesional and non-lesional skin samples of psoriatic patients and/or the encoded proteins. DEGs were determined by microarray meta-analysis using MetaOMICS package. We used STRING for protein-protein, CisRED for protein-DNA and STITCH for chemical-protein interaction network construction. General network-, cluster- and motif-analysis were carried out in each network. Many DEG-coded proteins (CCNA2, FYN, PIK3R1, CTGF, F3) and transcription factors (AR, TFDP1, MEF2A, MECOM) were identified as central nodes, suggesting their potential role in psoriasis pathogenesis. CCNA2, TFDP1 and MECOM might play role in the hyperproliferation of keratinocytes, whereas FYN may be involved in the disturbed immunity in psoriasis. AR can be an important link between inflammation and insulin resistance, while MEF2A has role in insulin signaling. A controller sub-network was constructed from interlinked positive feedback loops that with the capability to maintain psoriatic lesional phenotype. Analysis of chemical-protein interaction networks detected 34 drugs with previously confirmed disease-modifying effects, 23 drugs with some experimental evidences, and 21 drugs with case reports suggesting their positive or negative effects. In addition, 99 unpublished drug candidates were also found, that might serve future treatments for psoriasis.
Conflict of interest statement
Figures





Similar articles
-
Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways.Curr Pharm Des. 2020;26(29):3619-3630. doi: 10.2174/1381612826666200311130133. Curr Pharm Des. 2020. PMID: 32160841
-
Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis.Hereditas. 2020 Jul 15;157(1):30. doi: 10.1186/s41065-020-00141-1. Hereditas. 2020. PMID: 32669126 Free PMC article.
-
Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?OMICS. 2015 Nov;19(11):669-87. doi: 10.1089/omi.2015.0096. Epub 2015 Oct 19. OMICS. 2015. PMID: 26480058 Free PMC article.
-
Pathogenesis of psoriasis.Dermatol Clin. 1995 Oct;13(4):723-37. Dermatol Clin. 1995. PMID: 8785878 Review.
-
Genetic polymorphisms altering microRNA activity in psoriasis--a key to solve the puzzle of missing heritability?Exp Dermatol. 2014 Sep;23(9):620-4. doi: 10.1111/exd.12469. Exp Dermatol. 2014. PMID: 24917490 Review.
Cited by
-
Integrative systems biology framework discovers common gene regulatory signatures in mechanistically distinct inflammatory skin diseases.NPJ Syst Biol Appl. 2025 Feb 27;11(1):21. doi: 10.1038/s41540-025-00498-x. NPJ Syst Biol Appl. 2025. PMID: 40016271 Free PMC article.
-
Using Micro- and Macro-Level Network Metrics Unveils Top Communicative Gene Modules in Psoriasis.Genes (Basel). 2020 Aug 10;11(8):914. doi: 10.3390/genes11080914. Genes (Basel). 2020. PMID: 32785106 Free PMC article.
-
Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.Cell Death Dis. 2020 Jan 10;11(1):21. doi: 10.1038/s41419-019-2212-y. Cell Death Dis. 2020. PMID: 31924750 Free PMC article.
-
Therapeutic drug monitoring of biologics in psoriasis.Biologics. 2019 Jul 5;13:127-132. doi: 10.2147/BTT.S188286. eCollection 2019. Biologics. 2019. PMID: 31308623 Free PMC article. Review.
-
Review-Current Concepts in Inflammatory Skin Diseases Evolved by Transcriptome Analysis: In-Depth Analysis of Atopic Dermatitis and Psoriasis.Int J Mol Sci. 2020 Jan 21;21(3):699. doi: 10.3390/ijms21030699. Int J Mol Sci. 2020. PMID: 31973112 Free PMC article. Review.
References
-
- Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133: 377–385. - PubMed
-
- Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370: 263–271. - PubMed
-
- Farkas A, Kemeny L (2012) Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle. Int Immunopharmacol 13: 215–218. - PubMed
-
- Armstrong AW, Harskamp CT, Armstrong EJ (2013) Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous